Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090571
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2004-08-27
Brief Title:
Juvenile Rheumatoid Arthritis Research Registry
Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Organization:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Study Overview
Official Title:
Research Registry for Juvenile Arthritis
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Juvenile rheumatoid arthritis JRA is the most common chronic inflammatory disease in children and may be related to genetics Having two siblings who both have JRA in one family is rare The purpose of this registry is to collect patient information and blood samples from qualifying JRA siblings and their families The goal of the registry is to further understanding of JRA as related to genetics
Detailed Description:
JRA is the most common chronic inflammatory pediatric rheumatic disease JRA may be related to a complex genetic trait It is rare to have two or more affected siblings or sibpairs within one family The JRA ASP Affected Sibpair Registry is a nationwide effort and will collect information and blood samples from JRA sibpairs and their families Unaffected family members eg mother father and unaffected children are also invited to participate
Patients and their families may enroll in the registry in one of two ways patients may contact the registry directly or they may be referred to the registry through their physician Once the family has qualified to join the registry the family will be asked to complete a questionnaire on the medical history of their JRA-affected members Physicians of the JRA-affected members will be asked to complete questionnaires about their patients conditions Family members will also be invited to provide a one-time blood sample Information collected through the registry will help researchers identify genes involved in JRA susceptibility
Patients and their families may enroll in the registry in one of two ways patients may contact the registry directly or they may be referred to the registry through their physician Once the family has qualified to join the registry the family will be asked to complete a questionnaire on the medical history of their JRA-affected members Physicians of the JRA-affected members will be asked to complete questionnaires about their patients conditions Family members will also be invited to provide a one-time blood sample Information collected through the registry will help researchers identify genes involved in JRA susceptibility
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| N01AR42272-8-0-1 | NIH | None | None |
| NIAMS-102N01-04-03 | OTHER | NIAMS NIH | httpsreporternihgovquickSearchN01AR42272-8-0-1 |